Target intelligence / Profile preview

Src Homology Phosphotyrosyl Phosphatase 2 (SHP2)

Target
SHP2
Molecular classification
Enzyme, Protein Tyrosine Phosphatase, Non-receptor tyrosine phosphatase
01

Overview

SHP2 is a non-receptor protein tyrosine phosphatase encoded by the PTPN11 gene. It plays a crucial role in various cell signaling pathways, including RAS/MAPK, PI3K/AKT, and JAK/STAT, regulating cell growth, proliferation, and differentiation. SHP2 consists of two SH2 domains (N-SH2 and C-SH2), a PTP catalytic domain, and a C-terminal tail. Its activity is regulated by auto-inhibition, where the N-SH2 domain blocks the PTP active site. Binding of phosphorylated ligands to the N-SH2 relieves this inhibition, activating SHP2. Mutations in PTPN11/SHP2 are implicated in several diseases, including Noonan syndrome, LEOPARD syndrome, hematologic malignancies, and solid tumors. Due to its central role in cancer-related signaling, SHP2 has emerged as an important drug target, with inhibitors targeting allosteric sites under development for cancer therapy.

Other names
PTPN11SH-PTP2Protein tyrosine phosphatase non-receptor type 11
02

Mechanism of action

Allosteric inhibition of SHP2

03

Biological functions

Signal transductionCell growthCell proliferationCell differentiationRegulation of RAS/MAPK pathwayRegulation of PI3K/AKT pathwayRegulation of JAK/STAT pathway
04

Disease associations

Noonan syndromeLEOPARD syndromeJuvenile myelomonocytic leukemiaHematologic malignanciesSolid tumorsCancer
05

Safety considerations

Potential for off-target effects due to involvement in multiple signaling pathwaysDevelopment of resistance to SHP2 inhibitors

Beyond the preview

Go deeper on Src Homology Phosphotyrosyl Phosphatase 2 (SHP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Src Homology Phosphotyrosyl Phosphatase 2 (SHP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call